CRISPR Therapeutics AG Total Assets for the year ending December 31, 2024: USD 2.24 B

CRISPR Therapeutics AG Total Assets is USD 2.24 B for the year ending December 31, 2024, a 0.56% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
  • CRISPR Therapeutics AG Total Assets for the year ending December 31, 2023 was USD 2.23 B, a -0.60% change year over year.
  • CRISPR Therapeutics AG Total Assets for the year ending December 31, 2022 was USD 2.24 B, a -18.49% change year over year.
  • CRISPR Therapeutics AG Total Assets for the year ending December 31, 2021 was USD 2.75 B, a 50.54% change year over year.
  • CRISPR Therapeutics AG Total Assets for the year ending December 31, 2020 was USD 1.83 B, a 71.36% change year over year.
Key Data
Date Total Assets Accounts Payable Short-Term Debt Long-Term Debt